Immuneering IMRX
NASDAQ IMRX
$4.07 +0.04 (+0.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuneering (IMRX) Change in Accured Expenses (2020 - 2026)

Updated

Immuneering's Change in Accured Expenses came in at $1.03 million for Q2 2026, down 10.4% from $1.15 million a year earlier.

Analysis

Immuneering (IMRX) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Immuneering reported Change in Accured Expenses of -$390,086; for FY2025, it came in at $2.9 million.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 42.8% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was -$200,831 in FY2024, $721,989 in FY2023 (+52.1%), $474,568 in FY2022 (-85.4%) and $3.24 million in FY2021 (+563.3%).
  • The five-year range for quarterly Change in Accured Expenses is -$4.78 million (Q1 2026) to $2.37 million (Q3 2025).
  • Year-over-year, Change in Accured Expenses increased in two of the last six quarters, with growth averaging 39.4%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q3 2025 (growth of 183.2%), and the weakest in Q2 2023 (a decline of 96.2%).
  • Business Quant data shows IMRX's Change in Accured Expenses at -$4.78 million (Q1 2026), $990,501 (Q4 2025) and $2.37 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Immuneering 263.32 Mn 263.32 Mn - 1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 -4.78 Mn
Dec 31, 2025 990,501.00
Sep 30, 2025 2.37 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 -1.61 Mn
Dec 31, 2024 380,304.00
Sep 30, 2024 835,677.00
Jun 30, 2024 1.35 Mn
Mar 31, 2024 -2.76 Mn
Dec 31, 2023 1.95 Mn
Sep 30, 2023 849,878.00
Jun 30, 2023 19,269.00
Mar 31, 2023 -2.09 Mn
Dec 31, 2022 89,032.00
Sep 30, 2022 2.11 Mn
Jun 30, 2022 507,883.00
Mar 31, 2022 -2.24 Mn
Dec 31, 2021 551,080.00
Sep 30, 2021 69,982.00
API Access

Immuneering Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMRX&period=max&api_key=YOUR_API_KEY